The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection

Abstract Background Coronavirus disease 2019 (COVID-19) is spreading fast all around the world with more than fourteen millions of detected infected cases and more than 600.000 deaths by 20th July 2020. While scientist are working to find a vaccine, current epidemiological data shows that the most c...

Full description

Bibliographic Details
Main Authors: Alberto Sainz-Cort, Joost H. Heeroma
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Journal of Cannabis Research
Subjects:
Online Access:https://doi.org/10.1186/s42238-020-00030-4
_version_ 1818695988027588608
author Alberto Sainz-Cort
Joost H. Heeroma
author_facet Alberto Sainz-Cort
Joost H. Heeroma
author_sort Alberto Sainz-Cort
collection DOAJ
description Abstract Background Coronavirus disease 2019 (COVID-19) is spreading fast all around the world with more than fourteen millions of detected infected cases and more than 600.000 deaths by 20th July 2020. While scientist are working to find a vaccine, current epidemiological data shows that the most common comorbidities for patients with the worst prognosis, hypertension and diabetes, are often treated with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs). Body Both ACE inhibitors and ARBs induce overexpression of the angiotensin converting enzyme 2 (ACE-2) receptor, which has been identified as the main receptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter into the alveolar cells of the lungs. While cannabinoids are known to reduce hypertension, the studies testing the hypotensive effects of cannabinoids never addressed their effects on ACE-2 receptors. However, some studies have linked the endocannabinoid system (ECS) with the renin angiotensin system (RAS), including a cross-modulation between the cannabinoid receptor 1 (CB1) and angiotensin II levels. Conclusion Since there are around 192 million people using cannabis worldwide, we believe that the mechanism underlying the hypotensive properties of cannabinoids should be urgently studied to understand if they can also lead to ACE-2 overexpression as other antihypertensive drugs do.
first_indexed 2024-12-17T13:54:13Z
format Article
id doaj.art-6f0964130c074c27b4f19beab014edd1
institution Directory Open Access Journal
issn 2522-5782
language English
last_indexed 2024-12-17T13:54:13Z
publishDate 2020-07-01
publisher BMC
record_format Article
series Journal of Cannabis Research
spelling doaj.art-6f0964130c074c27b4f19beab014edd12022-12-21T21:45:58ZengBMCJournal of Cannabis Research2522-57822020-07-01211410.1186/s42238-020-00030-4The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infectionAlberto Sainz-Cort0Joost H. Heeroma1GH MedicalGH MedicalAbstract Background Coronavirus disease 2019 (COVID-19) is spreading fast all around the world with more than fourteen millions of detected infected cases and more than 600.000 deaths by 20th July 2020. While scientist are working to find a vaccine, current epidemiological data shows that the most common comorbidities for patients with the worst prognosis, hypertension and diabetes, are often treated with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs). Body Both ACE inhibitors and ARBs induce overexpression of the angiotensin converting enzyme 2 (ACE-2) receptor, which has been identified as the main receptor used by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter into the alveolar cells of the lungs. While cannabinoids are known to reduce hypertension, the studies testing the hypotensive effects of cannabinoids never addressed their effects on ACE-2 receptors. However, some studies have linked the endocannabinoid system (ECS) with the renin angiotensin system (RAS), including a cross-modulation between the cannabinoid receptor 1 (CB1) and angiotensin II levels. Conclusion Since there are around 192 million people using cannabis worldwide, we believe that the mechanism underlying the hypotensive properties of cannabinoids should be urgently studied to understand if they can also lead to ACE-2 overexpression as other antihypertensive drugs do.https://doi.org/10.1186/s42238-020-00030-4COVID-19HypertensionCannabisACE-2SARS-CoV-2Endocannabinoid
spellingShingle Alberto Sainz-Cort
Joost H. Heeroma
The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection
Journal of Cannabis Research
COVID-19
Hypertension
Cannabis
ACE-2
SARS-CoV-2
Endocannabinoid
title The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection
title_full The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection
title_fullStr The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection
title_full_unstemmed The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection
title_short The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection
title_sort interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for covid 19 infection
topic COVID-19
Hypertension
Cannabis
ACE-2
SARS-CoV-2
Endocannabinoid
url https://doi.org/10.1186/s42238-020-00030-4
work_keys_str_mv AT albertosainzcort theinteractionbetweentheendocannabinoidsystemandthereninangiotensinsystemanditspotentialimplicationforcovid19infection
AT joosthheeroma theinteractionbetweentheendocannabinoidsystemandthereninangiotensinsystemanditspotentialimplicationforcovid19infection
AT albertosainzcort interactionbetweentheendocannabinoidsystemandthereninangiotensinsystemanditspotentialimplicationforcovid19infection
AT joosthheeroma interactionbetweentheendocannabinoidsystemandthereninangiotensinsystemanditspotentialimplicationforcovid19infection